Basic Full Body
Full Body66 parametersReport in 24HrsAt Home
Fasting Required
Details
Essential Health covering Blood, Diabetes, Heart, Liver, Kidney, Thyroid, Iron, Sugar, Inflammation, Bone
₹788₹1,399
44% OFF
FREE:AI InsightsDoctor Consultation
Parameters
- List of Tests
- Sugar (Glucose) Random
- CBC - Complete Hemogram
- Liver Function Test
- Albumin
- Alkaline Phosphatase
- Bilirubin - Direct
- Bilirubin - Indirect
- Bilirubin - Total
- AST/SGOT
- ALT/SGPT
- Total Protein
- A/G Ratio
- Gamma GT
- Globulin
- Kidney Profile
- BUN
- Calcium
- Creatinine
- Uric Acid
- eGFR
- BUN/Creatinine
- Urea
- Lipid Profile
- Cholestrol/HDL
- LDL/HDL
- Non HDL
- VLDL
- Total Cholestrol
- Triglycerides
- HDL
- LDL
- Iron Studies
- Iron
- TIBC
- Transferrin Saturation
- Thyroid Profile
- Total T3
- Total T4
- TSH
- Hba1c
- eAG
- ESR
- Calcium
Basic Wellness Package - Comprehensive Medical Test Guide
- Why is it done?
- Comprehensive health screening to assess overall metabolic, hematologic, hepatic, renal, and endocrine function in asymptomatic individuals
- Early detection of chronic diseases including diabetes, hypertension, thyroid disorders, anemia, liver disease, and kidney disease
- Baseline assessment for routine medical check-ups, annual physicals, or preventive health maintenance programs
- Sugar (Glucose) Random: Screens for hyperglycemia and diabetes mellitus; detects abnormal glucose metabolism
- CBC - Complete Hemogram: Evaluates red blood cells, white blood cells, and platelets to detect anemia, infection, leukemia, and bleeding disorders
- Liver Function Test: Assesses liver synthetic and metabolic function; detects hepatitis, cirrhosis, fatty liver disease, and biliary obstruction
- Kidney Profile: Evaluates renal function and electrolyte balance; detects chronic kidney disease, acute kidney injury, and metabolic abnormalities
- Lipid Profile: Assesses cardiovascular risk by measuring blood lipids; identifies dyslipidemia and atherosclerosis risk
- Iron Studies: Evaluates iron metabolism and storage; detects iron deficiency anemia or iron overload disorders
- Thyroid Profile: Assesses thyroid hormone production and pituitary function; detects hyperthyroidism, hypothyroidism, and thyroid disorders
- HbA1c and eAG: Provides long-term glycemic control assessment over 2-3 months; evaluates diabetes management and risk
- ESR (Erythrocyte Sedimentation Rate): Non-specific marker for inflammation; helps identify systemic inflammatory or infectious diseases
- Calcium: Assesses bone health and parathyroid function; detects hypercalcemia and hypocalcemia-related disorders
- Tests work synergistically to provide a complete health snapshot, enabling clinicians to identify multiple organ system abnormalities and develop comprehensive treatment strategies
- Normal Range
- Sugar (Glucose) Random: 70-100 mg/dL (fasting) or <140 mg/dL (random); Normal indicates adequate glucose control
- CBC - Complete Hemogram: Hemoglobin: 13.5-17.5 g/dL (males), 12.0-15.5 g/dL (females); RBC: 4.5-5.9 million/μL (males), 4.1-5.1 million/μL (females); WBC: 4,500-11,000/μL; Platelets: 150,000-400,000/μL
- Liver Function Test: Albumin: 3.5-5.0 g/dL; Alkaline Phosphatase: 30-120 IU/L; Bilirubin Total: 0.1-1.2 mg/dL; Bilirubin Direct: 0.0-0.3 mg/dL; Bilirubin Indirect: 0.1-0.9 mg/dL; AST/SGOT: 10-40 IU/L; ALT/SGPT: 7-56 IU/L; Total Protein: 6.0-8.3 g/dL; A/G Ratio: 1.0-2.5; Gamma GT: 0-65 IU/L; Globulin: 2.0-3.5 g/dL
- Kidney Profile: BUN: 7-20 mg/dL; Creatinine: 0.7-1.3 mg/dL (males), 0.6-1.1 mg/dL (females); eGFR: >60 mL/min/1.73m²; Uric Acid: 3.5-7.2 mg/dL (males), 2.6-6.0 mg/dL (females); Calcium: 8.5-10.2 mg/dL; Urea: 15-45 mg/dL; BUN/Creatinine Ratio: 10-20
- Lipid Profile: Total Cholesterol: <200 mg/dL; HDL: >40 mg/dL (males), >50 mg/dL (females); LDL: <100 mg/dL (optimal); Triglycerides: <150 mg/dL; VLDL: <40 mg/dL; LDL/HDL Ratio: <3.0; Cholesterol/HDL Ratio: <5.0; Non-HDL: <130 mg/dL
- Iron Studies: Iron: 60-170 μg/dL (males), 50-150 μg/dL (females); TIBC: 250-425 μg/dL; Transferrin Saturation: 20-50%
- Thyroid Profile: Total T3: 80-180 ng/dL; Total T4: 5.0-12.0 μg/dL; TSH: 0.4-4.0 mIU/L
- HbA1c: <5.7% indicates normal glycemic control; eAG: <100 mg/dL correlates with HbA1c <5.7%
- ESR: <20 mm/hr (males <50 years), <30 mm/hr (males >50 years), <20 mm/hr (females <50 years), <30 mm/hr (females >50 years)
- Calcium: 8.5-10.2 mg/dL or 2.1-2.55 mmol/L indicates normal serum calcium levels essential for bone and muscle function
- Interpretation
- Sugar (Glucose) Random: Elevated (>140 mg/dL random) suggests hyperglycemia, impaired fasting glucose, or diabetes mellitus; <70 mg/dL indicates hypoglycemia requiring immediate intervention; values 100-125 mg/dL (fasting) suggest impaired fasting glucose
- CBC - Complete Hemogram: Elevated hemoglobin suggests polycythemia or dehydration; Low hemoglobin (<12 g/dL females, <13.5 g/dL males) indicates anemia; Elevated WBC (>11,000/μL) suggests infection or leukemia; Low WBC (<4,500/μL) indicates immunosuppression; Low platelets (<150,000/μL) suggests thrombocytopenia or bleeding risk
- Liver Function Test: Elevated AST/ALT (>40 IU/L) indicates hepatocellular injury from hepatitis or cirrhosis; Elevated Alkaline Phosphatase (>120 IU/L) suggests biliary obstruction or bone disease; Elevated bilirubin (>1.2 mg/dL) indicates jaundice, hemolysis, or cholestasis; Low albumin (<3.5 g/dL) suggests malnutrition or liver disease; Elevated Gamma GT suggests alcohol use or biliary disease; Abnormal A/G ratio may indicate liver disease or immune disorders
- Kidney Profile: Elevated creatinine (>1.3 mg/dL males, >1.1 mg/dL females) indicates reduced glomerular filtration; eGFR <60 mL/min/1.73m² indicates chronic kidney disease; Elevated BUN (>20 mg/dL) suggests renal dysfunction or dehydration; Elevated uric acid indicates gout risk or renal disease; Elevated calcium (>10.2 mg/dL) may cause nephrolithiasis or bone disease; Low calcium (<8.5 mg/dL) indicates hypoparathyroidism or vitamin D deficiency; Elevated BUN/Creatinine ratio (>20) suggests prerenal azotemia
- Lipid Profile: Total cholesterol >200 mg/dL indicates increased cardiovascular risk; HDL <40 mg/dL (males) or <50 mg/dL (females) is protective factor loss; LDL >100 mg/dL increases atherosclerosis risk; Triglycerides >150 mg/dL indicates hypertriglyceridemia; Elevated LDL/HDL and Cholesterol/HDL ratios suggest poor lipid metabolism; Non-HDL >130 mg/dL indicates atherogenic dyslipidemia
- Iron Studies: Low iron (<60 μg/dL males, <50 μg/dL females) with high TIBC suggests iron deficiency anemia; Elevated iron (>170 μg/dL males, >150 μg/dL females) with low TIBC indicates hemochromatosis or iron overload; Transferrin saturation >50% suggests iron overload; Transferrin saturation <20% suggests iron deficiency
- Thyroid Profile: Elevated TSH (>4.0 mIU/L) with low Total T4 indicates primary hypothyroidism; Low TSH (<0.4 mIU/L) with elevated Total T3/T4 indicates hyperthyroidism; Normal TSH with abnormal T3/T4 suggests secondary thyroid dysfunction; Subclinical hypothyroidism shows elevated TSH with normal thyroid hormones
- HbA1c: 5.7-6.4% indicates prediabetes requiring lifestyle intervention; ≥6.5% confirms diabetes mellitus diagnosis; <5.7% indicates normal glycemic control; Useful for distinguishing acute hyperglycemia from chronic poor control; eAG provides glucose average for better patient understanding
- ESR: Elevated ESR indicates systemic inflammation, infection, malignancy, or autoimmune disease; Non-specific marker requiring correlation with clinical presentation; Serial measurements help monitor disease activity and treatment response; Mild elevations may occur with age, anemia, or pregnancy
- Calcium: Hypercalcemia (>10.2 mg/dL) causes polyuria, polydipsia, renal stones, and cardiac arrhythmias; Hypocalcemia (<8.5 mg/dL) causes tetany, seizures, and muscle weakness; Mild variations may reflect albumin changes; Ionized calcium more accurate than total calcium in liver disease or hypoalbuminemia
- Associated Organs
- Sugar (Glucose) Random: Pancreas (insulin production), Liver (glucose metabolism), Kidneys (glucose reabsorption); Evaluates endocrine and metabolic function; Abnormalities indicate diabetes mellitus, metabolic syndrome, or insulinoma
- CBC - Complete Hemogram: Bone marrow (hematopoiesis), Spleen (hemolysis), Lymph nodes (immune function), Lungs (respiratory infection); Evaluates hematologic system; Abnormalities indicate anemia, leukemia, lymphoma, infection, or clotting disorders
- Liver Function Test: Liver (primary target organ) - all 11 parameters reflect hepatic synthetic, metabolic, and secretory function; Biliary system (bile duct patency), Hemolytic system (bilirubin source); Abnormalities indicate hepatitis, cirrhosis, cholestasis, bile duct obstruction, hemolytic anemia, or hepatic malignancy; Portal hypertension affects albumin and bilirubin levels
- Kidney Profile: Kidneys (glomerular filtration, tubular reabsorption), Parathyroid glands (calcium-phosphate regulation), Bone (mineral metabolism); eGFR and creatinine assess glomerular filtration; BUN/urea reflect protein metabolism; Calcium imbalances indicate parathyroid or renal disease; Abnormalities indicate chronic kidney disease, acute kidney injury, glomerulonephritis, or secondary hyperparathyroidism
- Lipid Profile: Liver (lipid synthesis and metabolism), Arterial system (atherosclerosis risk), Heart (coronary artery disease risk), Small intestine (lipid absorption); All lipid parameters synthesized or metabolized by liver; Abnormalities indicate dyslipidemia, metabolic syndrome, or familial lipid disorders; Complications include myocardial infarction, stroke, peripheral arterial disease, and sudden cardiac death
- Iron Studies: Bone marrow (erythropoiesis), Liver (iron storage and ferritin), Spleen (iron recycling from hemolysis), Gastrointestinal tract (iron absorption); Iron, TIBC, transferrin synthesized by liver; Abnormalities indicate iron deficiency anemia, hemochromatosis, or sideroblastic anemia; Complications include anemia, organ fibrosis, or secondary infection
- Thyroid Profile: Thyroid gland (hormone production), Pituitary gland (TSH secretion), Hypothalamus (TRH secretion); TSH reflects pituitary-thyroid axis integrity; T3 and T4 reflect thyroid hormone production; Abnormalities indicate Graves' disease, Hashimoto's thyroiditis, thyroid cancer, or pituitary dysfunction; Complications include cardiac arrhythmias, myxedema, or thyroid storm
- HbA1c and eAG: Pancreas (beta cell function and insulin secretion), Red blood cells (hemoglobin glycation), Kidneys (glucose excretion); Reflects average blood glucose over 2-3 months; Helps assess complications risk; Abnormalities indicate diabetes control failure and increased microvascular/macrovascular complication risk
- ESR: Non-specific systemic inflammation marker affecting multiple organs; Indicates acute or chronic inflammatory/infectious processes; Immune system activation; Malignant disease burden; Abnormalities suggest systemic diseases including rheumatoid arthritis, systemic lupus erythematosus, tuberculosis, endocarditis, or malignancy
- Calcium: Bones (mineral storage and skeletal integrity), Parathyroid glands (calcium regulation via PTH), Kidneys (calcium reabsorption and vitamin D activation), Intestines (calcium absorption); Maintained within tight range for muscle contraction, nerve conduction, and blood coagulation; Abnormalities indicate parathyroid disease, renal disease, vitamin D deficiency, or bone disease; Complications include osteoporosis, nephrolithiasis, cardiac arrhythmias, or neuromuscular dysfunction
- Follow-up Tests
- Sugar (Glucose) Random: Fasting glucose, Oral glucose tolerance test (OGTT), Continuous glucose monitoring (CGM), Insulin level, C-peptide level; Repeat testing annually for prediabetic patients; Every 3-6 months for diabetic patients on treatment
- CBC - Complete Hemogram: Peripheral blood smear, Bone marrow biopsy (if cytopenias), Reticulocyte count, Vitamin B12 and folate levels, Iron studies; Repeat CBC in 2 weeks for confirmed anemia; Weekly for severe cytopenias; Refer to hematology for WBC >20,000/μL or platelets <50,000/μL
- Liver Function Test: Liver ultrasound for cirrhosis evaluation, Hepatitis serologies (A, B, C) if jaundiced, Autoimmune hepatitis markers, Prothrombin time (PT/INR), Albumin levels, Alpha-fetoprotein (AFP) for hepatocellular carcinoma screening; Repeat LFTs in 1 week for elevated enzymes; Refer to gastroenterology for persistent elevations
- Kidney Profile: Renal ultrasound for structural abnormalities, Urine protein-to-creatinine ratio, Urine microscopy, Cystatin C (alternative GFR marker), Renal biopsy (if indicated), 24-hour urine protein; Repeat kidney profile every 3-6 months if eGFR <60; Refer to nephrology if eGFR <30 or rapid decline; Uric acid monitoring in patients on diuretics
- Lipid Profile: Lipoprotein(a), ApoB, Homocysteine, hsCRP (high-sensitivity C-reactive protein), Carotid intima-media thickness (CIMT), Coronary calcium scoring; Repeat lipid profile in 4-12 weeks after therapy initiation; Annual screening if normal; Refer to cardiology for CIMT >0.75 mm or very high LDL
- Iron Studies: Serum ferritin, Free iron, Hemoglobin electrophoresis (if suspected hemolytic anemia), Bone marrow biopsy, Liver MRI for iron quantification; Repeat iron studies 1-2 months after treatment initiation; Monitor ferritin every 3 months in hemochromatosis patients; Refer to hematology for severe deficiency or overload
- Thyroid Profile: Free T3, Free T4, Thyroid antibodies (TPO, thyroglobulin), TSI (thyroid stimulating immunoglobulin), Thyroid ultrasound; Repeat TSH in 6-8 weeks after therapy changes; Annual screening if normal; Monthly monitoring if dose adjustments needed; Refer to endocrinology for TSI positive or thyroid nodules
- HbA1c and eAG: Fasting glucose, OGTT, HbA1c (every 3-6 months), Home glucose monitoring, Diabetes complications screening (annual eye exam, foot exam, urine albumin); Repeat HbA1c every 3 months until stable, then every 6 months; Annual kidney function assessment; Refer to endocrinology if HbA1c >9% despite treatment
- ESR: Repeat ESR to track disease progression, Specific inflammatory markers (CRP, procalcitonin), Imaging studies (X-ray, CT, MRI) based on clinical suspicion; Combine with clinical assessment and other labs; Serial ESR measurements assess treatment response; Refer to infectious disease or rheumatology if ESR persistently elevated without clear etiology
- Calcium: Ionized calcium, Phosphate, Magnesium, Parathyroid hormone (PTH), Vitamin D (25-OH vitamin D), Alkaline phosphatase; Repeat calcium with albumin adjustment; Annual bone density screening (DEXA scan) if low; Vitamin D supplementation if <30 ng/mL; Refer to endocrinology if persistent abnormalities; Parathyroid imaging if high-normal PTH with hypercalcemia
- Fasting Required?
- Overall: YES - Fasting 8-12 hours is REQUIRED for optimal test accuracy, particularly for glucose, lipid profile, and kidney function measurements
- Ideal timing: Collect blood sample in early morning after 8-12 hours fasting (typically 6:00-8:00 AM after overnight fast)
- Water intake: Clear water only is permitted during fasting period; no other beverages allowed
- Dietary restrictions: Nothing to eat or drink except water after 10:00 PM the night before; avoid alcohol 24 hours prior to testing
- Medications: Continue taking all regular medications with small amount of water unless otherwise instructed; especially important for cardiac and blood pressure medications; Inform laboratory technician of all medications
- Sugar (Glucose) Random: Requires fasting for accurate comparison; Random sample without fasting is acceptable only for screening purposes but less reliable for diagnosis
- CBC - Complete Hemogram: May be performed non-fasting; minimal food effect; hydration status may affect hematocrit slightly
- Liver Function Test: May be performed non-fasting; less affected by food intake than lipids; bilirubin relatively stable regardless of fasting
- Kidney Profile: May be performed non-fasting; creatinine and urea not significantly affected by food; BUN relatively stable
- Lipid Profile: MUST REQUIRE fasting 8-12 hours; triglycerides significantly elevated if non-fasting; cholesterol minimally affected; LDL calculation requires fasting triglycerides; non-fasting results not comparable to population guidelines
- Iron Studies: May be performed non-fasting; iron levels may fluctuate with meals but less critical than glucose or lipids; morning collection preferred for consistency
- Thyroid Profile: May be performed non-fasting; TSH and thyroid hormones not significantly affected by food intake; consistent timing preferred for serial measurements
- HbA1c and eAG: Non-fasting acceptable; reflects average glucose over 2-3 months; fasting status does not affect results; can be collected anytime during day
- ESR: May be performed non-fasting; minimal food effect; hydration slightly affects result; ideally collected after morning rest
- Calcium: May be performed non-fasting; total calcium relatively stable; protein binding may affect results slightly with food intake
- Special conditions: Inform technician of recent illness, vigorous exercise, or stress (can elevate ESR and some liver enzymes); Report recent transfusions (affect CBC); Disclose herbal supplements or nutritional modifications (affect iron, lipids); Note menstrual cycle if female (affects CBC and iron studies)
- Test validity: Fasting lipid profile is standard for cardiovascular risk assessment; non-fasting lipid results have different interpretation and are less clinically useful for screening; Repeat testing should maintain same fasting status for comparison
How our test process works!
